94 related articles for article (PubMed ID: 18326526)
1. Hepatocyte growth factor promotes migration of human myeloma cells.
Holt RU; Fagerli UM; Baykov V; Rø TB; Hov H; Waage A; Sundan A; Børset M
Haematologica; 2008 Apr; 93(4):619-22. PubMed ID: 18326526
[TBL] [Abstract][Full Text] [Related]
2. Human myeloma cells adhere to fibronectin in response to hepatocyte growth factor.
Holt RU; Baykov V; Rø TB; Brabrand S; Waage A; Sundan A; Børset M
Haematologica; 2005 Apr; 90(4):479-88. PubMed ID: 15820943
[TBL] [Abstract][Full Text] [Related]
3. Mn2+ regulates myeloma cell adhesion differently than the proadhesive cytokines HGF, IGF-1, and SDF-1alpha.
Slørdahl TS; Hov H; Holt RU; Baykov V; Syversen T; Sundan A; Waage A; Børset M
Eur J Haematol; 2008 Dec; 81(6):437-47. PubMed ID: 18774952
[TBL] [Abstract][Full Text] [Related]
4. A selective c-met inhibitor blocks an autocrine hepatocyte growth factor growth loop in ANBL-6 cells and prevents migration and adhesion of myeloma cells.
Hov H; Holt RU; Rø TB; Fagerli UM; Hjorth-Hansen H; Baykov V; Christensen JG; Waage A; Sundan A; Børset M
Clin Cancer Res; 2004 Oct; 10(19):6686-94. PubMed ID: 15475459
[TBL] [Abstract][Full Text] [Related]
5. HGF and IGF-1 synergize with SDF-1α in promoting migration of myeloma cells by cooperative activation of p21-activated kinase.
Rø TB; Holien T; Fagerli UM; Hov H; Misund K; Waage A; Sundan A; Holt RU; Børset M
Exp Hematol; 2013 Jul; 41(7):646-55. PubMed ID: 23499762
[TBL] [Abstract][Full Text] [Related]
6. The involvement of stromal derived factor 1alpha in homing and progression of multiple myeloma in the 5TMM model.
Menu E; Asosingh K; Indraccolo S; De Raeve H; Van Riet I; Van Valckenborgh E; Vande Broek I; Fujii N; Tamamura H; Van Camp B; Vanderkerken K
Haematologica; 2006 May; 91(5):605-12. PubMed ID: 16627256
[TBL] [Abstract][Full Text] [Related]
7. The hepatocyte growth factor/Met pathway controls proliferation and apoptosis in multiple myeloma.
Derksen PW; de Gorter DJ; Meijer HP; Bende RJ; van Dijk M; Lokhorst HM; Bloem AC; Spaargaren M; Pals ST
Leukemia; 2003 Apr; 17(4):764-74. PubMed ID: 12682635
[TBL] [Abstract][Full Text] [Related]
8. Osteoblasts promote migration and invasion of myeloma cells through upregulation of matrix metalloproteinases, urokinase plasminogen activator, hepatocyte growth factor and activation of p38 MAPK.
Hecht M; Heider U; Kaiser M; von Metzler I; Sterz J; Sezer O
Br J Haematol; 2007 Aug; 138(4):446-58. PubMed ID: 17593251
[TBL] [Abstract][Full Text] [Related]
9. Stromal cell-derived factor-1/CXCR4 enhanced motility of human osteosarcoma cells involves MEK1/2, ERK and NF-kappaB-dependent pathways.
Huang CY; Lee CY; Chen MY; Yang WH; Chen YH; Chang CH; Hsu HC; Fong YC; Tang CH
J Cell Physiol; 2009 Oct; 221(1):204-12. PubMed ID: 19496172
[TBL] [Abstract][Full Text] [Related]
10. Crucial role of phosphatase CD45 in determining signaling and proliferation of human myeloma cells.
Collette M; Descamps G; Pellat-Deceunynck C; Bataille R; Amiot M
Eur Cytokine Netw; 2007 Sep; 18(3):120-6. PubMed ID: 17823079
[TBL] [Abstract][Full Text] [Related]
11. Antimyeloma activity of the orally bioavailable dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235.
McMillin DW; Ooi M; Delmore J; Negri J; Hayden P; Mitsiades N; Jakubikova J; Maira SM; Garcia-Echeverria C; Schlossman R; Munshi NC; Richardson PG; Anderson KC; Mitsiades CS
Cancer Res; 2009 Jul; 69(14):5835-42. PubMed ID: 19584292
[TBL] [Abstract][Full Text] [Related]
12. The novel orally bioavailable inhibitor of phosphoinositol-3-kinase and mammalian target of rapamycin, NVP-BEZ235, inhibits growth and proliferation in multiple myeloma.
Baumann P; Mandl-Weber S; Oduncu F; Schmidmaier R
Exp Cell Res; 2009 Feb; 315(3):485-97. PubMed ID: 19071109
[TBL] [Abstract][Full Text] [Related]
13. The effects of thalidomide on chemotactic migration of multiple myeloma cell lines.
Fuchida SI; Shimazaki C; Hirai H; Akamatsu S; Yamada N; Uchida R; Okano A; Okamoto M; Inaba T; Taniwaki M
Int J Lab Hematol; 2008 Jun; 30(3):220-9. PubMed ID: 18479301
[TBL] [Abstract][Full Text] [Related]
14. Calpain-mediated regulation of the distinct signaling pathways and cell migration in human neutrophils.
Katsube M; Kato T; Kitagawa M; Noma H; Fujita H; Kitagawa S
J Leukoc Biol; 2008 Jul; 84(1):255-63. PubMed ID: 18443189
[TBL] [Abstract][Full Text] [Related]
15. Characterization of in vitro growth of multiple myeloma cells.
Zlei M; Egert S; Wider D; Ihorst G; Wäsch R; Engelhardt M
Exp Hematol; 2007 Oct; 35(10):1550-61. PubMed ID: 17889722
[TBL] [Abstract][Full Text] [Related]
16. Rho/ROCK and MAPK signaling pathways are involved in glioblastoma cell migration and proliferation.
Zohrabian VM; Forzani B; Chau Z; Murali R; Jhanwar-Uniyal M
Anticancer Res; 2009 Jan; 29(1):119-23. PubMed ID: 19331140
[TBL] [Abstract][Full Text] [Related]
17. PC cell-derived growth factor (granulin precursor) expression and action in human multiple myeloma.
Wang W; Hayashi J; Kim WE; Serrero G
Clin Cancer Res; 2003 Jun; 9(6):2221-8. PubMed ID: 12796389
[TBL] [Abstract][Full Text] [Related]
18. IGF-1-stimulated protein synthesis in oligodendrocyte progenitors requires PI3K/mTOR/Akt and MEK/ERK pathways.
Bibollet-Bahena O; Almazan G
J Neurochem; 2009 Jun; 109(5):1440-51. PubMed ID: 19453943
[TBL] [Abstract][Full Text] [Related]
19. Noncompetitive inhibition of hepatocyte growth factor-dependent Met signaling by a phage-derived peptide.
Tam EM; Runyon ST; Santell L; Quan C; Yao X; Kirchhofer D; Skelton NJ; Lazarus RA
J Mol Biol; 2009 Jan; 385(1):79-90. PubMed ID: 18973760
[TBL] [Abstract][Full Text] [Related]
20. PI3K-Akt signaling regulates basal, but MAP-kinase signaling regulates radiation-induced XRCC1 expression in human tumor cells in vitro.
Toulany M; Dittmann K; Fehrenbacher B; Schaller M; Baumann M; Rodemann HP
DNA Repair (Amst); 2008 Oct; 7(10):1746-56. PubMed ID: 18678286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
